BL-M08D1 for nasopharyngeal cancer and other solid tumors
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This study tests a new drug called BL-M08D1 for people with nasopharyngeal cancer or other solid tumors that have returned or spread. The trial is in early phases to see how safe the drug is and whether it can shrink tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 75 years old.
- You need to have nasopharyngeal cancer or another solid tumor that has come back or spread to other parts of the body.
- You should be able to take care of yourself and do light activities (performance status 0 or 1).
- You must have a tumor that can be measured on imaging scans, and you must provide a tissue sample (from a previous biopsy or a new one).
- You need to have recovered from side effects of earlier cancer treatments and have acceptable organ function (heart, blood, kidneys, etc.).
- You cannot be pregnant or breastfeeding, and you must use effective birth control during the study and for 6 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing an experimental medication called BL-M08D1 for people with head and neck cancer that has come back or spread, as well as other types of solid tumors. The goal is to see if the drug is safe and effective.
This study tests an experimental drug called BL-M08D1 for people with recurrent or metastatic gynecological cancers and other solid tumors. The drug is designed to target and kill cancer cells, and the study aims to see if it is safe and effective.
This study tests a new drug called BL-M08D for people with advanced solid tumors, especially those in the digestive tract (like stomach, colon, or pancreas). The goal is to see if it is safe and effective, and it might help shrink tumors or slow their growth.
This trial is testing a new drug called BL-M08D for people with melanoma or other solid tumors that have spread. The drug aims to attack cancer cells, and researchers want to see if it is safe and effective.
This trial tests a new drug (BL-B01D1) given alone or with another drug that helps the immune system fight cancer (called a PD-1 inhibitor). It is for people with newly diagnosed, locally advanced nasopharyngeal cancer. The goal is to see if this combination can shrink or control the cancer better.
This trial tests whether adding a new drug (BL-B01D1) to an immunotherapy maintenance treatment can help keep nasopharyngeal cancer from growing after initial chemotherapy. It aims to improve how long patients live without the cancer progressing.
Hear when a new Nasopharyngeal Carcinoma (NPC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.